Precision BioSciences Inc (DTIL)
Healthcare
Biotechnology
7.00 $
-0.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Precision BioSciences Inc (DTIL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 77.5% of the shares are freely tradable; institutional investors hold 65.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
65.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
6.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
77.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
7.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
26Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Octagon Capital Advisors LP | 8.67 | 2,236,732 | +16.6 | 03/31/2026 |
| Aberdeen Group PLC | 8.64 | 2,230,178 | +4.3 | 03/31/2026 |
| Empery Asset Management, LP | 7.63 | 1,968,879 | -10.3 | 03/31/2026 |
| Bleichroeder LP | 6.44 | 1,662,500 | +0.0 | 03/31/2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 4.13 | 1,066,050 | +0.0 | 03/31/2026 |
| Driehaus Capital Management LLC | 3.86 | 995,371 | +26.4 | 03/31/2026 |
| Lynx1 Capital Management, LP | 3.82 | 985,113 | -0.9 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.53 | 910,740 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| abrdn World Healthcare | 4.43 | 1,144,208 | +0.0 | 04/30/2026 |
| abrdn Life Sciences Investors | 4.21 | 1,085,970 | +0.0 | 05/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.